VEGFA and neoplasm: Consistently, treatment of GBM patients with the angiogenesis inhibiting anti-vascular endothelial growth factor (VEGF) antibody bevacizumab is linked to enhanced invasion and multifocal tumour recurrence7, 8, 9, which is associated with aggravated mental decline.